Fair drug pricing in Germany

The "Fair drug pricing" conference will focus on the current trends in pricing and reimbursement in the high-price segment of innovative medicinal products in Germany ahead of the September general election.

Representatives of HTA body G-BA, pharma, payers, medical experts and MPs will discuss pricing and reimbursement models in the European context as well as data generation and data use in drug development and routine care. The conference is the major spring event organised by Forum-Institut für Management.

More information